ValuEngine downgraded shares of IntelGenx Technologies Corp. (OTCMKTS:IGXT) from a hold rating to a sell rating in a research note released on Saturday.
Separately, HC Wainwright set a $2.00 price target on IntelGenx Technologies and gave the company a buy rating in a research note on Monday, August 14th.
Shares of IntelGenx Technologies (OTCMKTS:IGXT) opened at $0.71 on Friday. The company has a debt-to-equity ratio of 1.53, a quick ratio of 2.65 and a current ratio of 2.65. IntelGenx Technologies has a 52 week low of $0.62 and a 52 week high of $1.09.
About IntelGenx Technologies
IntelGenx Technologies Corp. is a drug delivery company focusing on the development of orally administered drug delivery products based on its oral drug delivery technologies. The Company is a provider of product development services for the pharmaceutical industry, including the branded and generic pharmaceutical markets.
Receive News & Ratings for IntelGenx Technologies Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntelGenx Technologies Corp. and related companies with MarketBeat.com's FREE daily email newsletter.